We collaborate with academic labs, biobanks, and research consortia to uncover promising proteomic signals with translational promise but no clear path forward. We help shape hypotheses, define early use cases, and frame IP and validation strategies.

We work alongside scientific teams to build robust translational strategies - mapping cohorts, identifying enabling technologies, and designing experiments that de-risk clinical progression. Our goal: convert insight into structured, partner-ready diagnostic or therapeutic programs.

We build the partnerships needed to bring new diagnostics and drug targets to life - linking academia, platforms, funders, and public health systems. Whether advancing a single signature or scaling an ecosystem, we help ensure the right tools, people, and incentives are in place to drive implementation.